Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2016-08-31
Target enrollment:
Participant gender:
Summary
The objective of this study will be to investigate the safety and tolerability of olaparib
tablet when given orally to Japanese patients with advanced solid malignancies. In addition,
the pharmacokinetic profile, MTD (if possible) and efficacy of olaparib will be investigated.